Therefore, we predict that the transduced RPE cells will continually secrete mini-CR1 that will reach both the retina and choroid, thereby inhibiting complement overactivation in all anatomic compartments where complement overactivation has been demonstrated in AMD. This evidence concerns the gene CR1 and age-related macular degeneration.